AIMD: Ainos, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.25
Enterprise Value ($M) 10.06
Book Value ($M) 24.45
Book Value / Share 4.11
Price / Book 0.26
NCAV ($M) -4.92
NCAV / Share -0.83
Price / NCAV -1.27

Profitability (mra)
Return on Invested Capital (ROIC) -0.46
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 1.72
Current Ratio 1.85

Balance Sheet (mrq) ($M)
Current Assets 2.47
Assets 31.84
Liabilities 7.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.12
Operating Income -12.92
Net Income -13.77
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.69
Cash from Investing -0.10
Cash from Financing 4.92

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-11 13D/A Amarillo Biosciences Inc 50.84
01-29 13D/A Ainos Inc 62.05 -95.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-08 10-K U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K
2024-02-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 394 19,503 2.02
2024-05-02 710 1,009 70.37
2024-05-01 2,046 5,835 35.06
2024-04-30 973 4,053 24.01

(click for more detail)

Similar Companies
ADVM – Adverum Biotechnologies, Inc. AEZS – Aeterna Zentaris Inc.
AGEN – Agenus Inc. AKAN – Akanda Corp.
AKBA – Akebia Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io